Digex

Celmatix Therapeutics, based in New York City and Cambridge, MA, is at the forefront of pioneering new therapies for women's health, specifically focusing on ovarian health and its critical role beyond reproduction. The company is dedicated to addressing high unmet needs in women's health through innovative drug programs targeting conditions such as endometriosis, polycystic ovary syndrome (PCOS), and ovarian aging. With a robust pipeline of groundbreaking therapies and a recent award of $35 million from the Advanced Research Projects Agency for Health (ARPA-H), Celmatix is committed to transforming women's health by developing therapeutics that enhance the quality of life for women throughout their lifespans. Their research emphasizes the unique biology of women, aiming to create effective treatments that address the physiological challenges they face as they age. Generated from the website

MPFP pllc is an internationally renowned landscape architecture and urban design firm, recognized as one of the foremost pioneers exploring the social and physical dynamics that shape our urban spaces and global landscapes...

Thornton-Tomasetti Group, headquartered in New York City, is one of the leading building structural engineering firms with offices in various countries. It provides multidisciplinary design services to building industry clients. The company offers professional design services through its three divisions, including Thornton-Tomasetti Engineers Division, LZA Technology Division, and LZA Associates Division. It also offers a wide range of newsletters, brochures, papers, and technical publications and presentations. Thornton-Tomasetti Group has more than 10 offices throughout the United States, and also has offices in Hong Kong, Moscow and Shanghai. It employs more than 500 individuals worldwide. Thornton-Tomasetti Group was established in 1956 as Lev Zetlin & Associates.